Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M176,771Revenue $M24,890Net Margin (%)51.7Altman Z-Score7.9
Enterprise Value $M178,248EPS $7.4Operating Margin %64.0Piotroski F-Score8
P/E(ttm)13.7Beneish M-Score-2.3Pre-tax Margin (%)62.4Higher ROA y-yY
Price/Book10.310-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales7.15-y EBITDA Growth Rate %27.2Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow11.8y-y EBITDA Growth Rate %180ROA % (ttm)44.1Higher Current Ratio y-yY
Dividend Yield %0.4PEG0.5ROE % (ttm)93.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,470ROIC % (ttm)84.4Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDKen Fisher 2015-06-30 Add$97.72 - $122.21
($109.1)
$ 116.106%Add 0.26%791,630
GILDJulian Robertson 2015-03-31 Reduce-5.61%$94.91 - $107.18
($101.54)
$ 116.1014%Reduce 56.64%231,511
GILDLeon Cooperman 2015-03-31 Sold Out -0.96%$94.91 - $107.18
($101.54)
$ 116.1014%Sold Out0
GILDFirst Eagle Investment 2015-03-31 Reduce-0.3%$94.91 - $107.18
($101.54)
$ 116.1014%Reduce 99.97%400
GILDNWQ Managers 2015-03-31 Buy 0.14%$94.91 - $107.18
($101.54)
$ 116.1014%New holding113,100
GILDJohn Rogers 2015-03-31 Add0.1%$94.91 - $107.18
($101.54)
$ 116.1014%Add 11.07%891,645
GILDJoel Greenblatt 2015-03-31 Add0.07%$94.91 - $107.18
($101.54)
$ 116.1014%Add 9.73%1,107,732
GILDDavid Dreman 2015-03-31 Buy 0.05%$94.91 - $107.18
($101.54)
$ 116.1014%New holding5,580
GILDKen Fisher 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 116.1014%Add 2.35%789,615
GILDRonald Muhlenkamp 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 116.1014%Reduce 0.09%218,740
GILDMario Gabelli 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 116.1014%Add 16.13%49,470
GILDDodge & Cox 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 116.1014%Reduce 5.76%4,250
GILDKen Heebner 2014-12-31 Sold Out -4.7%$89.45 - $114.22
($103.4)
$ 116.1012%Sold Out0
GILDJulian Robertson 2014-12-31 Add1.67%$89.45 - $114.22
($103.3)
$ 116.1012%Add 20.27%533,911
GILDLeon Cooperman 2014-12-31 Buy 0.96%$89.45 - $114.22
($103.54)
$ 116.1012%New holding612,500
GILDFirst Eagle Investment 2014-12-31 Add0.3%$89.45 - $114.22
($103.4)
$ 116.1012%Add 328672.00%1,315,088
GILDJoel Greenblatt 2014-12-31 Add0.26%$89.45 - $114.22
($103.3)
$ 116.1012%Add 51.98%1,009,462
GILDRonald Muhlenkamp 2014-12-31 Add0.24%$89.45 - $114.22
($103.4)
$ 116.1012%Add 6.10%218,945
GILDJohn Rogers 2014-12-31 Add0.17%$89.45 - $114.22
($103.4)
$ 116.1012%Add 24.68%802,803
GILDVanguard Health Care Fund 2014-12-31 Sold Out -0.1%$89.45 - $114.22
($103.4)
$ 116.1012%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLIGAN JOHN FPresident and COO 2015-07-07Sell100,000$114.44-1.63view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-07-07Sell70,000$118.27-4.82view
Alton Gregg HEVP, Corp & Med Affairs 2015-07-01Sell17,000$116.73-3.56view
Carter Paul RutherfordEVP Commercial Ops 2015-07-01Sell3,000$118.24-4.8view
MARTIN JOHN CChairman and CEO 2015-07-01Sell150,000$116.46-3.34view
Cogan John FrancisDirector 2015-06-26Sell27,000$120.13-6.29view
Carter Paul RutherfordEVP Commercial Ops 2015-06-18Sell10,000$120-6.19view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-06-15Sell70,000$117.67-4.33view
MILLIGAN JOHN FPresident and COO 2015-06-08Sell100,000$114.05-1.3view
MARTIN JOHN CChairman and CEO 2015-06-01Sell150,000$113.95-1.21view

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
Weekly Insider Sells Highlight: GILD, AXTA, GME, DXCM Jul 14 2015 
Gilead Sciences is Still Undervalued Jul 06 2015 
Julian Robertson Discusses Greece Threat, Stocks and Apple Jun 30 2015 
Why I Am Buying Gilead Sciences Jun 30 2015 

More From Other Websites
Edited Transcript of GILD earnings conference call or presentation 28-Jul-15 8:30pm GMT Jul 29 2015
How a hugely overpriced hepatitis drug helped drive up U.S. health spending Jul 28 2015
5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen Jul 28 2015
Gilead Lifts Sales View As Hep C Drugs Top Jul 28 2015
Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
Gilead hepatitis C sales beat Wall Street, sales outlook raised Jul 28 2015
Gilead beats Street's 2Q forecasts on surge in sales, profit Jul 28 2015
Fast Money Final Trade: GILD, TWTR & YELP Jul 28 2015
Pricey hepatitis C drugs help Gilead eclipse big sales threshold Jul 28 2015
Gilead Sciences Announces Third Quarter 2015 Dividend Jul 28 2015
Gilead Sciences Announces Second Quarter 2015 Financial Results Jul 28 2015
Twitter Q2 Earnings Turns After-hours Rollercoaster - Analyst Blog Jul 28 2015
Gilead Sciences Inc. Posts Q2 Results, Able to Beat Earnings, Revenue Estimates - Stocks in the News Jul 28 2015
Express Scripts Raises Guidance as Earnings Top Views Jul 28 2015
Twitter soars on strong results; Yelp tanks Jul 28 2015
Gilead Tops Estimates in 2Q Jul 28 2015
Tuesday's After-Hours Movers: Twitter, Gilead, Yelp And Buffalo Wild Wings Jul 28 2015
Gilead Sciences (GILD) Stock Climbing in After Hours Trading Following Earnings Results Jul 28 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK